Viewing data from:

TROVAN/ZITHROMAX COMPLIANCE PAK

NDA

AZITHROMYCIN DIHYDRATE; TROVAFLOXACIN MESYLATE | N050762 | PFIZER PHARMACEUTICALS INC

1 strength0 unique patents0 unique exclusivities

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

No clinical trials found on ClinicalTrials.gov for this drug

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Dec 28, 1998	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — EQ 1GM BASE,N/A;N/A,EQ 100MG BASE

0 patents0 exclusivities▴

FOR SUSPENSION, TABLET;ORAL | Approved: Dec 18, 1998

No patent or exclusivity listings for this strength.